Improving Hypertension Management Through Preference List Defaults

Enrolling by invitation · Not applicable

Conditions studied: Hypertension, Clinical Decision Support, Choice Behavior, Quality Improvement

In brief

This study aims to evaluate whether modifying the EPIC preference list to display combination blood pressure (BP) medications at the top and/or adding "(PREFERRED)" to the beginning of the medication listing increases prescribing of these medications. Combination BP medications are aligned with value-based care guidelines and may improve patient adherence and reduce pill burden. Currently, these medications may be under-prescribed in part due to their low visibility in the EPIC prescribing interface.

Key facts

Study ID

NCT07298694

Run by

Geisinger Clinic

People needed

12150

Starts

2026-04-13

Expected to finish

2026-10-01

Last updated by the study team

2026-06-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Order placed for a medication starting with any of the following: "amlodipine", "benazepril", "valsartan", "lisinopril", "hctz", "hydrochlorothiazide", "hydro", "losartan"
• The order is placed at an in-person, virtual (telemed), telephone, or nurse encounter in a clinic included in the study
• Patient is age 18+
• Exclusion Criterion:
• Order placed by a clinical leader who was aware of the study or a clinician involved in study planning

Where it is running

• Geisinger — Danville, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.